BENDHEIM JACK (President and CEO) sold 26.7% of their position (12.32K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $541.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/26/2025ACC: 0001104659-25-116504
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-12.32K
Net shares
Net seller
$541.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
12.32K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−7.04K
Price / share
$43.93
Trade value
$309.24K
% of position
15.3%
11/25/2025
46.16K→39.12K
Class A Common Stock
Indirect
Shares
−5.28K
Price / share
$44.02
Trade value
$232.43K
% of position
13.5%
11/26/2025
39.12K→33.84K
Total
Net shares
−12.32K
Net value
-$541.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 11/25/2025 | S · Sale | −7.04K | $43.93 | $309.24K | 15.3% | 46.16K | 39.12K |
| Class A Common Stock Indirect | 11/26/2025 | S · Sale | −5.28K | $44.02 | $232.43K | 13.5% | 39.12K | 33.84K |
| Total | −12.32K | -$541.67K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported